Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/23159
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23342299      線上人數 : 457
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/23159


    標題: A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA
    作者: Meng-ChiYen
    Chi-Chen Lin
    Yi-Ling Chen
    Shih-Shien Huang
    Huei-JiunYang
    Chih-Peng Chang
    Huan-Yao Lei
    Ming-Derg Lai
    貢獻者: 老人服務事業管理系
    日期: 2009-01
    上傳時間: 2010-10-28 16:05:39 (UTC+8)
    摘要: Purpose: Indoleamine 2,3-dioxygenase (IDO), an enzyme that degrades tryptophan, is a negative immune regulatorym olecule of dendritic cells. IDO-expressing dendritic cells suppress Tcell responses and maybe immunosuppressive in vivo.We hypothesized that silencing the IDO expression in skin dendritic cells in vivo could elicit antitumor activityi n tumor-draining lymph nodes.
    Experimental Design: The efficiencyo f IDO-specific small interfering RNA (siRNA) was evaluated in vitro and in vivo. The therapeutic effect was evaluated in MBT-2 murine bladder tumor model and CT-26 colon tumor models.
    Results: IDO expression was down-regulated in CD11c-positive lymphocytes after IDO siRNA treatment. In vivo skin administration of IDO siRNA inhibited tumor growth and prolonged survival in both tumor models. The number of infiltrated Tcells and neutrophils increased at tumor sites, which are correlated with therapeutic efficacy.TheTcells may be mainly responsible for the immunologic rejection because the effect was abolished byd epletion of CD8-positiveT cells.
    Adoptive transfer of CD11c-positive dendritic cells from vaccinated mice delayed tumor progression. The cancer therapeutic effect was reproduciblyobservedwith another IDO siRNA targeting at different site, suggesting the effect was not due to off-target effect. In a neu-overexpressing MBT-2 tumor model, IDO siRNA enhanced the therapeutic efficacyo f Her2/Neu DNA vaccine. Down-regulation of IDO2, an IDO homologue, with siRNA also generated antitumor immunity
    in vivo.
    Conclusions: Antitumor immunityca n be effectively elicited by physical deliveryof siRNAs targeting immunoregulatoryg enes in skin dendritic cells in vivo, as shown byI DO and IDO2 in this report.
    關聯: Clin Cancer Res. 15(2):p.641-649
    顯示於類別:[高齡福祉養生管理系] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML2043檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋